calcitriol
FDA Approved
Description
Calcitriol is the active form of vitamin D3 used to manage hypocalcemia and metabolic bone disease. It is essential for calcium homeostasis and bone metabolism. In genetic hypoparathyroidism, it helps maintain adequate serum calcium levels when parathyroid hormone is deficient or absent.
Indications & Therapeutic Use
hypoparathyroidism, hypocalcemia, renal osteodystrophy, genetic hypoparathyroidism
Linked Diseases:
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
calcitriol
| Generic Name | calcitriol |
| Brands | 1 brand available |
| Active Ingredient | calcitriol |
| Drug Class | hypoparathyroidism |
| Manufacturer | Validus Pharmaceuticals |
| Dosage Forms | oral capsule 0.25mcg, 0.5mcg; oral solution 1mcg/mL; IV injection 1mcg/mL |
| Medical Code | A11CC04 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes